Upstart benefits from moderating macroeconomic risks, strong loan origination growth, and expanding funding partnerships, with automated originations at 91% improving margins. Management reaffirms strong guidance for fiscal years 2026 and 2028, emphasizing multi-year profitable growth despite mixed first-quarter 2026 performance. Investors are advised to temper expectations for Q2 2026 earnings due to likely uneven loan originations linked to prior geopolitical tensions. The stock remains attractive at a P/E of 14.95x and a 3-year PEG ratio of 0.40x compared to historical levels and peers, making it a compelling buy for contrarian investors despite ongoing macroeconomic normalization and high short interest.
